Scholars Central

CommentaryPublished 2 May 2024

MicroRNA-181a-5p Could be One of Potential Therapeutic Strategies for ALF

Authors: Yuqiao Zeng, Likun Wang

1Department of the Infection Control Center, Shandong Second Medical University, Shandong, China; 2Department of the Infection Control Center, Linyi People’s Hospital of Shandong Second Medical University, Shandong, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The study of miRNAs has flourished during the decade, and several specific miRNA expression profiles have been identified in liver disease. This short commentary on the research of microRNA-181a-5p, evaluated the strengths and limitations of the article MicroRNA- 181a-5p alleviates acute liver failure in mice by inhibiting High Mobility Group Box 1 (HMGB1), aimed to explore the therapeutic prospects of microRNA-181a-5p in Acute Liver Failure (ALF).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cellular and Molecular Biology.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCellular and Molecular Biology
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Yuqiao Zeng”
  • BylineArticles whose byline prints “Likun Wang”